Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients. Int. J. Res. Clin. Hosp. Pharm. [Internet]. 2019 Sep. 14 [cited 2026 Jul. 26];2(1):1-4. Available from: https://rubatosisjournals.com/index.php/ijrhcp/article/view/333